In our book, The Missing Wellness Factors—EPA and DHA, Jørn Dyerberg, M.D., Dr. Med. Sc., and I discuss how EPA and DHA have been shown to reduce the risk of certain cancers having an inflammatory component (1). We discussed the 2010 review by Helena Gleissman, Ph.D., and coworkers of the Karolinska Institute in Sweden that associated the consumption of omega-3 fatty acids with decreased risk of cancers of the breast, prostate, colon and kidneys (2). We also described the supportive animal study by Kelavkar et al. (3). While we did not specifically discuss prostate cancer in detail, this cancer does seem to have an inflammatory component and early studies support the premise that EPA and DHA can be protective.